Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Metastatic Breast Cancer|Stage IV Breast Cancer
Interventions: OTHER: Discontinuation of Anti-HER-2 Maintenance Treatment
Sponsor: University of Miami